David V. Elkins - EVP, Chief Financial Officer at Bristol Myers Squibb Co

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Financial Officer
Stock Symbol
BMY, CELG-RI on NYSE, BMYMP on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by David V. Elkins since 12/22/2023

Holdings reported by David V. Elkins for Bristol Myers Squibb Co

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.10 par value 195K $10.5M $53.79 Mar 10, 2024 Direct
Market Share Units 41.8K $2.25M $53.79 Mar 10, 2024 Direct Common Stock, $0.10 par value
Common Stock, $0.10 par value 216 $11.6K $53.79 Mar 10, 2024 BMS Savings and Investment Program
Performance Shares 62.7K Mar 10, 2024 Direct Common Stock, $0.10 par value
Restricted Stock Units 0 $50.10 Dec 2, 2023 Direct Common Stock, $0.10 par value

Transactions reported by David V. Elkins for Bristol Myers Squibb Co

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.